Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
22 hedge funds and large institutions have $546K invested in Guardion Health Sciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
4% less funds holding
Funds holding: 23 → 22 (-1)
17% less capital invested
Capital invested by funds: $659K → $546K (-$113K)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.5K |
| 2 |
Jane Street
New York
|
+$4.45K |
| 3 |
HF
HRT Financial
New York
|
+$3.52K |
| 4 |
Morgan Stanley
New York
|
+$2.27K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$99.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.1K |
| 3 |
E
Ergoteles
New York
|
-$19K |
| 4 |
VF
Virtu Financial
New York
|
-$11K |
| 5 |
Renaissance Technologies
New York
|
-$8.52K |
GHSI Hedge Fund Activity: Q4 2022 in Review
22 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2022, worth a combined $546K — down 17% from $659K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GHSI and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $7.5K. The largest seller was Millennium Management, cutting an estimated $99.4K.
- 22 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2022, down from 23 in Q3 2022.
- Funds reported $546K of Guardion Health Sciences, Inc. Common Stock stock for Q4 2022, down 17% quarter-over-quarter.
- 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2022 and 5 closed out, a net change of -1 holder.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2022 was Citadel Advisors, an estimated $7.5K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2022 was Millennium Management, an estimated $99.4K sold.
Based on aggregated 13F filings for Q4 2022.